Results Snapshot
Figures in Million
Consolidate Annual Results
Jan'25
Jan'24
Jan'23
Jan'22
Jan'21
Jan'20
Jan'19
Net Sales
17.90
22.60
24.89
17.38
11.35
11.85
22.36
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
17.90
22.60
24.89
17.38
11.35
11.85
22.36
Raw Material Cost
9.38
11.46
13.81
9.86
6.18
5.91
9.07
Purchase of Finished goods
0.00
0.00
0.00
0.00
0.00
0.00
0.00
(Increase) / Decrease In Stocks
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Employee Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
2.01
1.07
0.75
0.24
0.05
0.31
0.38
Selling and Distribution Expenses
11.39
13.77
15.72
10.66
8.07
9.05
9.62
Other Expenses
0.24
0.44
0.53
0.45
0.29
0.24
0.39
Total Expenditure (Excl Depreciation)
25.17
30.71
35.57
25.30
17.19
17.65
22.95
Operating Profit (PBDIT) excl Other Income
-7.3
-8.100000000000001
-10.700000000000001
-7.9
-5.8
-5.8
-0.6
Other Income
-0.00
0.03
0.20
0.07
-0.03
-0.22
-1.21
Operating Profit (PBDIT)
-2.95
-3.22
-5.62
-7.06
-3.30
-3.44
0.75
Interest
2.01
1.07
0.75
0.24
0.05
0.31
0.38
Exceptional Items
-0.87
-9.59
-0.08
4.13
-0.14
-1.56
-3.68
Gross Profit (PBDT)
8.52
11.14
11.08
7.52
5.17
5.95
13.29
Depreciation
4.33
4.86
4.86
3.65
2.58
2.57
2.55
Profit Before Tax
-10.16
-18.74
-11.31
-6.81
-6.06
-7.88
-5.87
Tax
0.00
-0.05
0.07
0.11
-1.26
-1.63
0.00
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
-10.16
-18.70
-11.38
-6.92
-4.80
-6.53
-5.87
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
-10.16
-18.70
-11.38
-6.92
-4.80
-6.53
-5.87
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
-10.16
-18.70
-11.38
-6.92
-4.80
-6.53
-5.87
Equity Capital
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Face Value
0.01
0.01
0.01
0.01
0.01
0.01
0.01
Reserves
12.28
18.81
35.51
34.04
17.49
16.00
6.20
Earnings per share (EPS)
-2.53
-4.96
-3.46
-2.29
-2.84
1.34
-4.5
Diluted Earnings per share
-2.53
-4.96
-3.46
-2.29
-2.84
1.34
-4.5
Operating Profit Margin (Excl OI)
-40.61%
-35.9%
-42.92%
-62.02%
-51.48%
-48.88%
-2.62%
Gross Profit Margin
-32.59%
-61.46%
-25.91%
-18.19%
-30.7%
-44.76%
-14.84%
PAT Margin
-56.75%
-82.74%
-45.72%
-39.8%
-42.3%
-55.05%
-26.22%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Annual Analysis Highlights
Net Sales
YoY Growth in year ended Jan 2025 is -20.80% vs -9.24% in Jan 2024
Consolidate Net Profit
YoY Growth in year ended Jan 2025 is 45.45% vs -64.04% in Jan 2024
Operating Profit (PBDIT) excl Other Income
YoY Growth in year ended Jan 2025 is 12.12% vs 43.10% in Jan 2024
Interest
YoY Growth in year ended Jan 2025 is 81.82% vs 57.14% in Jan 2024
Operating Profit Margin (Excl OI)
YoY Growth in year ended Jan 2025 has fallen from Jan 2024
Compare Annual Results Of Streamline Health Solutions, Inc. With
Figures in Million
Consolidate Annual Results
Change(USD)
Change(%)
Net Sales
17.90
26.35
-8.45
-32.07%
Other Operating Income
0.00
0.00
0.00
Total Operating income
17.90
26.35
-8.45
-32.07%
Raw Material Cost
9.38
6.94
2.44
35.16%
Purchase of Finished goods
0
0
0.00
(Increase) / Decrease In Stocks
0
0
0.00
Employee Cost
0.00
0.00
0.00
Power Cost
0
0
0.00
Manufacturing Expenses
2.01
0.00
2.01
Selling and Distribution Expenses
11.39
14.41
-3.02
-20.96%
Other Expenses
0.24
0.30
-0.06
-20.00%
Total Expenditure (Excl Depreciation)
25.17
24.35
0.82
3.37%
Operating Profit (PBDIT) excl Other Income
-7.27
2.00
-9.27
-463.50%
Other Income
-0.00
0.25
-0.25
-100.00%
Operating Profit (PBDIT)
-2.95
3.67
-6.62
-180.38%
Interest
2.01
0.00
2.01
Exceptional Items
-0.87
0.00
-0.87
Gross Profit (PBDT)
8.52
19.41
-10.89
-56.11%
Depreciation
4.33
1.42
2.91
204.93%
Profit Before Tax
-10.16
2.25
-12.41
-551.56%
Tax
0.00
0.89
-0.89
-100.00%
Provisions and contingencies
0
0
0.00
Profit After Tax
-10.16
1.36
-11.52
-847.06%
Extraordinary Items
0.00
0.00
0.00
Prior Period Expenses
0
0
0.00
Other Adjustments
0
0
0.00
Net Profit
-10.16
1.36
-11.52
-847.06%
Share in Profit of Associates
0
0
0.00
Minority Interest
0.00
0.00
0.00
Other related items
0.00
0.00
0.00
Consolidated Net Profit
-10.16
1.36
-11.52
-847.06%
Equity Capital
0
0
0.00
Face Value
0.01
0.00
0.00
Reserves
12.28
45.69
-33.41
-73.12%
Earnings per share (EPS)
-2.53
0.12
-2.65
-2,208.33%
Diluted Earnings per share
-2.53
0.12
-2.65
-2,208.33%
Operating Profit Margin (Excl OI)
-40.61%
7.58%
0.00
-48.19%
Gross Profit Margin
-32.59%
13.92%
0.00
-46.51%
PAT Margin
-56.75%
5.18%
0.00
-61.93%
Public Share Holdings (%)
0%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0%
0%
0.00
0.00%
Annual - Net Sales
Net Sales 1.79 Million
in Jan 2025Figures in Million
YoY Growth in year ended Jan 2025 is -20.80% vs -9.24% in Jan 2024
Annual - Consolidate Net Profit
Consolidate Net Profit -1.02 Million
in Jan 2025Figures in Million
YoY Growth in year ended Jan 2025 is 45.45% vs -64.04% in Jan 2024
Annual - Operating Profit (PBDIT)
Operating Profit (PBDIT) -0.29 Million
in Jan 2025Figures in Million
YoY Growth in year ended Jan 2025 is 12.12% vs 43.10% in Jan 2024
Annual - Interest
Interest 0.20 Million
in Jan 2025Figures in Million
YoY Growth in year ended Jan 2025 is 81.82% vs 57.14% in Jan 2024
Annual - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) -40.61%
in Jan 2025Figures in %
YoY Growth in year ended Jan 2025 has fallen from Jan 2024






